4//SEC Filing
STEINMETZ MICHAEL 4
Accession 0001209191-12-037738
CIK 0001339455other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 2:10 PM ET
Size
16.5 KB
Accession
0001209191-12-037738
Insider Transaction Report
Form 4
EVNIN LUKE
10% Owner
Transactions
- Sale
Common Stock
2012-07-06$0.29/sh−671,217$195,324→ 2,900,460 total(indirect: See Footnote) - Sale
Common Stock
2012-07-09$0.31/sh−1,624,574$498,744→ 1,275,886 total(indirect: See Footnote)
GALAKATOS NICHOLAS
10% Owner
Transactions
- Sale
Common Stock
2012-07-06$0.29/sh−671,217$195,324→ 2,900,460 total(indirect: See Footnote) - Sale
Common Stock
2012-07-09$0.31/sh−1,624,574$498,744→ 1,275,886 total(indirect: See Footnote)
WHEELER KURT
Director
Transactions
- Sale
Common Stock
2012-07-09$0.31/sh−1,624,574$498,744→ 1,275,886 total(indirect: See Footnote) - Sale
Common Stock
2012-07-06$0.29/sh−671,217$195,324→ 2,900,460 total(indirect: See Footnote)
GADICKE ANSBERT
10% Owner
Transactions
- Sale
Common Stock
2012-07-09$0.31/sh−1,624,574$498,744→ 1,275,886 total(indirect: See Footnote) - Sale
Common Stock
2012-07-06$0.29/sh−671,217$195,324→ 2,900,460 total(indirect: See Footnote)
HENNER DENNIS
10% Owner
Transactions
- Sale
Common Stock
2012-07-09$0.31/sh−1,624,574$498,744→ 1,275,886 total(indirect: See Footnote) - Sale
Common Stock
2012-07-06$0.29/sh−671,217$195,324→ 2,900,460 total(indirect: See Footnote)
STEINMETZ MICHAEL
10% Owner
Transactions
- Sale
Common Stock
2012-07-06$0.29/sh−671,217$195,324→ 2,900,460 total(indirect: See Footnote) - Sale
Common Stock
2012-07-09$0.31/sh−1,624,574$498,744→ 1,275,886 total(indirect: See Footnote)
SIMON NICHOLAS J III
10% Owner
Transactions
- Sale
Common Stock
2012-07-06$0.29/sh−671,217$195,324→ 2,900,460 total(indirect: See Footnote) - Sale
Common Stock
2012-07-09$0.31/sh−1,624,574$498,744→ 1,275,886 total(indirect: See Footnote)
Footnotes (4)
- [F1]The shares were sold as follows: 559,506 by MPM BioVentures III-QP, L.P. ("BV III QP"), 37,622 by MPM BioVentures III, L.P. ("BV III"), 9,907 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 16,901 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 47,281 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
- [F2]The shares are held as follows: 2,417,716 by BV III QP, 162,570 by BV III, 42,835 by AM 2005, 73,032 by BV Parallel and 204,307 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
- [F3]The shares were sold as follows: 1,354,196 by BV III QP, 91,057 by BV III, 23,979 by AM 2005, 40,907 by BV Parallel and 114,435 by BV KG.
- [F4]The shares are held as follows: 1,063,520 by BV III QP, 71,513 by BV III, 18,856 by AM 2005, 32,125 by BV Parallel and 89,872 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001166285
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 2:10 PM ET
- Size
- 16.5 KB